Tomohiko Nishino

Tomohiko Nishino

Auto-generated profile, based on publicly available information

Tomohiko Nishino

Department of Pediatrics, Teikyo University School of Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2024 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
TNTomohiko Nishino
Tomohiko Nishino
STShinya Tomori
Shinya Tomori
MHMei Haruyama
Mei Haruyama
KTKazuhiro Takahashi
Kazuhiro Takahashi
MMMasakazu Mimaki
Masakazu Mimaki

12 April 2024 in ESMO Open
Verified
Journal Article
Open access
TKTakashi Kubo
Takashi Kubo
KSKuniko Sunami
Kuniko Sunami
TKTakafumi Koyama
Takafumi Koyama
MKM. Kitami
M. Kitami
YFY. Fujiwara
Y. Fujiwara
NYN. Yamamoto
N. Yamamoto
Comprehensive genome profiling (CGP) serves as a guide for suitable genomically matched therapies for patients with cancer. However, little is known about the impact of the timing and types of cancer on the therapeutic benefit of CGP. A single hospital-based pan-cancer prospective study (TOP-GEAR; UMIN000011141) was conducted to examine the benefit of CGP with respect to the timing and types of cancer. Patients with advanced solid tumors (>30 types) who either progressed with or without standard treatments were genotyped using a single CGP test. The subjects were followed up for a median duration of 590 days to examine therapeutic response, using progression-free survival (PFS), PFS ratio, and factors associated with therapeutic response. Among the 507 patients, 62 (12.2%) received matched therapies with an overall response rate (ORR) of 32.3%. The PFS ratios (≥1.3) were observed in 46.3% (19/41) of the evaluated patients. The proportion of subjects receiving such therapies in the rare cancer cohort was lower than that in the non-rare cancer cohort (9.6% and 17.4%, respectively; P = 0.010). However, ORR of the rare cancer patients was higher than that in the non-rare cancer cohort (43.8% and 20.0%, respectively; P = 0.046). Moreover, ORR of matched therapies in the first or second line after receiving the CGP test was higher than that in the third or later lines (62.5% and 21.7%, respectively; P = 0.003). Rare cancer and early-line treatment were significantly and independently associated with ORR of matched therapies in multivariable analysis (P = 0.017 and 0.004, respectively). Patients with rare cancer preferentially benefited from tumor mutation profiling by increasing the chances of therapeutic response to matched therapies. Early-line treatments after profiling increase the therapeutic benefit, irrespective of tumor types.

15 April 2021 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
TNTomohiko Nishino
Tomohiko Nishino
SEShota Endo
Shota Endo
HMHiroki Miyano
Hiroki Miyano
YTYoichi Takemasa
Yoichi Takemasa
MSMasahito Saito
Masahito Saito
SFShuichiro Fujinaga
Shuichiro Fujinaga

17 November 2020 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
TNTomohiko Nishino
Tomohiko Nishino
SEShota Endo
Shota Endo
HMHiroki Miyano
Hiroki Miyano
CUChisato Umeda
Chisato Umeda
YTYuji Tomii
Yuji Tomii
SFShuichiro Fujinaga
Shuichiro Fujinaga

14 July 2021 in Pain and Therapy
Verified
Journal Article
Open access
PDF file
TNTomohiko Nishino
Tomohiko Nishino
NINaoki Ito
Naoki Ito
STShinya Tomori
Shinya Tomori
SSSatoshi Shimada
Satoshi Shimada
MKMisaki Kodera
Misaki Kodera
MMMasakazu Mimaki
Masakazu Mimaki
Introduction A major goal in neonatal medicine is to reduce stress as much as possible in routine care. Bathing is one of the important routine cares for neonates, but it makes a big environmental change for them. We aimed to examine whether water temperature, room temperature, and position changes in tub bathing serve as noxious stimuli to neonates. Methods This prospective trial was performed in full-term and non-low-birth-weight neonates admitted to the hospital between July 2020 and March 2021. Those with underlying diseases, fetal distress, infection, and other medical conditions were excluded. Measurements were taken during the neonates’ first tub bath since birth, which was performed by a trained nurse. Changes in regional oxygen saturation (rSO2), determined using near-infrared spectroscopy, and water and room temperature, were examined at five different time points: upon entering the bath, head washing, position change, exiting the bath, and during the 3 min after bathing. Results In total, 17 neonates were analyzed. No changes in rSO2 due to head washing or position change were observed; however, rSO2 significantly decreased upon entering (78.5 ± 4.1% vs. 75.7 ± 4.1%, p < 0.001) and exiting the bath (75.8 ± 5.7% vs. 74.4 ± 5.4%, p < 0.04). The rate change in rSO2 upon entering the bath showed a significant inverse correlation with water temperature (r = − 0.53, p < 0.03), and there were no significant correlations between rSO2 and water or room temperature upon exiting the bath. There was no change in body skin temperature before and after bathing, but rSO2 gradually decreased during the 3 min after bathing. Conclusions Neonates may perceive certain temperatures during bathing as noxious stimuli. Therefore, methods to minimize stress associated with bathing should be implemented to reduce the difference between water temperature and room temperature during bathing. Trial registration This trial has been registered at UMIN repository with the trial number UMIN000041045 (https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046500). The date of the final dataset was April 01, 2021.

24 September 2021 in Clinical and Experimental Nephrology
Verified
Journal Article
Closed access
PDF file
TNTomohiko Nishino
Tomohiko Nishino
KTKazuhiro Takahashi
Kazuhiro Takahashi
STShinya Tomori
Shinya Tomori
SOSayaka Ono
Sayaka Ono
MMMasakazu Mimaki
Masakazu Mimaki